BMY

Bristol-Myers
NYSE

Real-time Quotes | Nasdaq Last Sale

54.82
-0.92
-1.65%
Closed 19:22 04/01 EDT
OPEN
53.62
PREV CLOSE
55.74
HIGH
55.70
LOW
53.52
VOLUME
13.44M
TURNOVER
--
52 WEEK HIGH
68.34
52 WEEK LOW
42.48
MARKET CAP
124.03B
P/E (TTM)
24.95
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BMY stock price target is 70.82 with a high estimate of 79.00 and a low estimate of 50.00.

EPS

BMY News

More
  • Bristol-Myers Squibb (BMY) Stock Moves -1.58%: What You Should Know
  • Zacks · 11h ago
  • CLARIFICATION: B of A Securities Yesterday Maintained Buy on Bristol-Myers Squibb, Announced $75 Price Target
  • Benzinga · 19h ago
  • Heres what a team of Citi analysts say will save the global economy and the stock market
  • MarketWatch · 20h ago
  • The No. 1 Pharma Company Nabbed A Key Approval But Is It A Buy?
  • Investor's Business Daily · 21h ago

Industry

Pharmaceuticals
-2.46%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About BMY

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.
More

Webull offers kinds of Bristol-Myers Squibb Co stock information, including NYSE:BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions.